These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3080031)

  • 1. Antibody-mediated targeting of liposomes to erythrocytes in whole blood.
    Singhal A; Bali A; Gupta CM
    Biochim Biophys Acta; 1986 Jan; 880(1):72-7. PubMed ID: 3080031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunospecific targeting of immunoliposomes, F(ab')2 and IgG to red blood cells in vivo.
    Peeters PA; Oussoren C; Eling WM; Crommelin DJ
    Biochim Biophys Acta; 1988 Aug; 943(2):137-47. PubMed ID: 3401475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional drug targeting to erythrocytes in vivo using antibody bearing liposomes as drug vehicles.
    Agrawal AK; Singhal A; Gupta CM
    Biochem Biophys Res Commun; 1987 Oct; 148(1):357-61. PubMed ID: 3675583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-mediated targeting of liposomes to red cells in vivo.
    Singhal A; Gupta CM
    FEBS Lett; 1986 Jun; 201(2):321-6. PubMed ID: 3709813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody targeting of liposomes: cell specificity obtained by conjugation of F(ab')2 to vesicle surface.
    Heath TD; Fraley RT; Papahdjopoulos D
    Science; 1980 Oct; 210(4469):539-41. PubMed ID: 7423203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A non-covalent method of attaching antibodies to liposomes.
    Loughrey H; Bally MB; Cullis PR
    Biochim Biophys Acta; 1987 Jul; 901(1):157-60. PubMed ID: 3593723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of specific polyclonal antibodies for site specific drug targeting to malaria infected erythrocytes in vivo.
    Singh AM; Owais M; Varshney GC
    Indian J Biochem Biophys; 1993 Dec; 30(6):411-3. PubMed ID: 8005626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinity targeting of Sendai virions to desialized human erythrocytes using hybrid antibody molecules.
    Chejanovsky N; Fridlender B; Loyter A
    Biochim Biophys Acta; 1985 Jan; 812(2):353-60. PubMed ID: 2981547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunospecific targeting of liposomes to erythrocytes.
    Peeters PA; Claessens CA; Eling WM; Crommelin DJ
    Biochem Pharmacol; 1988 Jun; 37(11):2215-22. PubMed ID: 3377820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced red blood cell destruction by antibody fragments.
    Mqadmi A; Abramowitz S; Zheng X; Yazdanbakhsh K
    Immunohematology; 2006; 22(1):11-4. PubMed ID: 16563046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody coating of liposomes with 1-ethyl-3-(3-dimethyl-aminopropyl)carbodiimide and the effect on target specificity.
    Endoh H; Suzuki Y; Hashimoto Y
    J Immunol Methods; 1981; 44(1):79-85. PubMed ID: 7252176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunospecific targeting of liposomes to cells: a novel and efficient method for covalent attachment of Fab' fragments via disulfide bonds.
    Martin FJ; Hubbell WL; Papahadjopoulos D
    Biochemistry; 1981 Jul; 20(14):4229-38. PubMed ID: 7284322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irreversible coupling of immunoglobulin fragments to preformed vesicles. An improved method for liposome targeting.
    Martin FJ; Papahadjopoulos D
    J Biol Chem; 1982 Jan; 257(1):286-8. PubMed ID: 7053372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivo.
    Brezski RJ; Kinder M; Grugan KD; Soring KL; Carton J; Greenplate AR; Petley T; Capaldi D; Brosnan K; Emmell E; Watson S; Jordan RE
    MAbs; 2014; 6(5):1265-73. PubMed ID: 25517311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and performance of bispecific F(ab' gamma)2 antibody containing thioether-linked Fab' gamma fragments.
    Glennie MJ; McBride HM; Worth AT; Stevenson GT
    J Immunol; 1987 Oct; 139(7):2367-75. PubMed ID: 2958547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of anti-erythrocyte autoantibody-producing B cells by a physiological IgG-anti-F(ab')2 antibody and escape from suppression by tumour transformation; a model relevant for the pathogenesis of autoimmune haemolytic anaemia.
    Terness P; Marx U; Sandilands G; Roelcke D; Welschof M; Opelz G
    Clin Exp Immunol; 1993 Aug; 93(2):253-8. PubMed ID: 8394233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studies.
    Brouwers A; Mulders P; Oosterwijk E; Buijs W; Corstens F; Boerman O; Oyen W
    Cancer Biother Radiopharm; 2004 Aug; 19(4):466-77. PubMed ID: 15453961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-idiotypic antibodies to the Coombs antibody in NZB F1 mice.
    Cohen PL; Eisenberg RA
    J Exp Med; 1982 Jul; 156(1):173-80. PubMed ID: 6979603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of IGF-1R SPECT/CT imaging using 111In-labeled F(ab')2 and Fab fragments of the monoclonal antibody R1507.
    Heskamp S; van Laarhoven HW; Molkenboer-Kuenen JD; Bouwman WH; van der Graaf WT; Oyen WJ; Boerman OC
    Mol Pharm; 2012 Aug; 9(8):2314-21. PubMed ID: 22747077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vitro and in vivo anti-tumour activity of N-AcMEL-(Fab')2 conjugates.
    Smyth MJ; Pietersz GA; McKenzie IF
    Br J Cancer; 1987 Jan; 55(1):7-11. PubMed ID: 3814478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.